Prospective Evaluation of the StatusFirst™ CHF NT-proBNP Device in Human Whole Blood and Plasma Samples

Clinical trial NCT00734045 · COMPLETED

Trial details

NCT number: NCT00734045
Sponsor: Nanogen, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Congestive Heart Failure (CHF)

Start date: 2008-02-01
Primary completion: 2008-11-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.